Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More
52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 4 - 07 December 2010, vol.116, pp.577, (Summary Text)
